XML 21 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Adjustment
Retained Earnings
Adjustment
Adjusted Balance
Common Stock
Adjusted Balance
Additional Paid-In Capital
Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Adjusted Balance
Retained Earnings
Adjusted Balance
Treasury Stock
Adjusted Balance
Noncontrolling Interests in Subsidiaries
Adjusted Balance
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Treasury Stock
Noncontrolling Interests in Subsidiaries
Total
Balance (ASU 2016-13) at Dec. 29, 2019 $ (1,066) $ (1,066) $ 447 $ 219,047 $ (10,185) $ 204,631 $ (747,327) $ 15,665 $ (317,722)              
Balance at Dec. 29, 2019                   $ 447 $ 219,047 $ (10,185) $ 205,697 $ (747,327) $ 15,665 $ (316,656)
Balance (in shares) (ASU 2016-13) at Dec. 29, 2019     31,894                          
Balance (in shares) at Dec. 29, 2019                   31,894            
Net income                         29,057   1,004 30,061
Other comprehensive income (loss), net of tax                       (10,919)       (10,919)
Cash dividends on common stock                     132   (14,652)     (14,520)
Cash dividends on preferred stock                         (6,825)     (6,825)
Exercise of stock options                   $ 4 21,700         21,704
Exercise of stock options (in shares)                   373            
Stock-based compensation expense                     8,742         8,742
Issuance of restricted stock                     (4,468)     4,468    
Issuance of restricted stock (in shares)                   77            
Tax effect of restricted stock awards                     (1,579)         (1,579)
Distributions to noncontrolling interests                             (945) (945)
Other                     3   (107) 259   155
Other (in shares)                   5            
Balance at Jun. 28, 2020                   $ 451 243,577 (21,104) 212,104 (742,600) 15,724 (291,848)
Balance (in shares) at Jun. 28, 2020                   32,349            
Balance at Mar. 29, 2020                   $ 448 220,187 (20,768) 202,287 (744,463) 16,009 (326,300)
Balance (in shares) at Mar. 29, 2020                   31,971            
Net income                         20,614   630 21,244
Other comprehensive income (loss), net of tax                       (336)       (336)
Cash dividends on common stock                     77   (7,360)     (7,283)
Cash dividends on preferred stock                         (3,412)     (3,412)
Exercise of stock options                   $ 3 20,460         20,463
Exercise of stock options (in shares)                   346            
Stock-based compensation expense                     4,792         4,792
Issuance of restricted stock                     (1,760)     1,760    
Issuance of restricted stock (in shares)                   30            
Tax effect of restricted stock awards                     (196)         (196)
Distributions to noncontrolling interests                             (915) (915)
Other                     17   (25) 103   95
Other (in shares)                   2            
Balance at Jun. 28, 2020                   $ 451 243,577 (21,104) 212,104 (742,600) 15,724 (291,848)
Balance (in shares) at Jun. 28, 2020                   32,349            
Balance at Dec. 27, 2020                   $ 453 254,103 (14,168) 219,158 (741,724) 15,239 (266,939)
Balance (in shares) at Dec. 27, 2020                   32,545            
Net income                         66,137   1,236 67,373
Other comprehensive income (loss), net of tax                       3,933       3,933
Repurchase and conversion of Series B Convertible Preferred Stock                   $ 35 174,631   (110,783)     63,883
Repurchase and conversion of Series B Convertible Preferred Stock (in shares)                   3,489            
Cash dividends on common stock                     62   (14,906)     (14,844)
Cash dividends on preferred stock                         (4,121)     (4,121)
Exercise of stock options                   $ 1 8,099         8,100
Exercise of stock options (in shares)                   148            
Acquisition of Company common stock                           (8,188)   (8,188)
Acquisition of Company common stock (in shares)                   (83)            
Stock-based compensation expense                     8,202         8,202
Issuance of restricted stock                     (5,665)     5,665    
Issuance of restricted stock (in shares)                   109            
Tax effect of restricted stock awards                     (3,887)         (3,887)
Distributions to noncontrolling interests                             (1,185) (1,185)
Other                     63   (716) 428   (225)
Other (in shares)                   7            
Balance at Jun. 27, 2021                   $ 489 435,608 (10,235) 154,769 (743,819) 15,290 (147,898)
Balance (in shares) at Jun. 27, 2021                   36,215            
Balance at Mar. 28, 2021                   $ 453 251,285 (11,971) 242,119 (737,268) 15,282 (240,100)
Balance (in shares) at Mar. 28, 2021                   32,681            
Net income                         32,254   623 32,877
Other comprehensive income (loss), net of tax                       1,736       1,736
Repurchase and conversion of Series B Convertible Preferred Stock                   $ 35 174,631   (110,783)     63,883
Repurchase and conversion of Series B Convertible Preferred Stock (in shares)                   3,489            
Cash dividends on common stock                     31   (7,471)     (7,440)
Cash dividends on preferred stock                         (709)     (709)
Exercise of stock options                   $ 1 5,801         5,802
Exercise of stock options (in shares)                   107            
Acquisition of Company common stock                           (6,921)   (6,921)
Acquisition of Company common stock (in shares)                   (68)            
Stock-based compensation expense                     4,089         4,089
Issuance of restricted stock                     (294)     294    
Issuance of restricted stock (in shares)                   5            
Tax effect of restricted stock awards                     (52)         (52)
Distributions to noncontrolling interests                             (615) (615)
Other                     117   (641) 76   (448)
Other (in shares)                   1            
Balance at Jun. 27, 2021                   $ 489 $ 435,608 $ (10,235) $ 154,769 $ (743,819) $ 15,290 $ (147,898)
Balance (in shares) at Jun. 27, 2021                   36,215